Manufacturer record

Vertex Pharma Chemicals: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

5 batches manufactured by Vertex Pharma Chemicals (Puducherry) were declared Not of Standard Quality between December 2024 and March 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

5 records linked to Vertex Pharma Chemicals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
5Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Dec 2024 to Mar 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

5
NSQ batches since 2024
5
Products affected
Other
Most common failure
Mar 2026
Latest alert

Flagged batches per year

2024 · 12025 · 32026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Amitriptyline Tablets IP 25mg VSPT2545Mfg 2025-09 · Exp 2027-08 DescriptionDescription DTL, Bengaluru, KarnatakaState lab Mar 2026
Levocetirizine Hydrochloride & Montelukast Sodium Suspension(LEMONT KID) VS2538Mfg 2025-10 · Exp 2027-09 Failed Description and assay (For Levocetirizine hydrochloride) & Incorrect LabellingAssay DTL, PuducherryState lab Dec 2025
(Levosalbutamol Sulphate, Ambroxol Hydrochloride and Guaiphenesin Syrup) VS2523Mfg 2025-07 · Exp 2027-06 ContentOther Drugs Testing Laboratory, Chennai-06State lab Nov 2025
Moxivin-CV 625 (Amoxycillin and Potassium Calvulnate Tablets IP) VMIT2404Mfg 2024-10 · Exp 2026-09 The Sample does not conform to IP specification for Amoxycillin and Potassium Clavulanate Tablets with respect to Identification of Potassium Clavulanate, Uniformity of weight and content of Amoxycillin in Amoxycillin Trihydrate and Clavulanic Acid in Potassium Clavulanate (Deemed to be spurious).Identification DTL MaduraiState lab Apr 2025
O Mak-200 VMWT240 7Mfg 2024-06 · Exp 2026-03 Sample does not conform to IP Specification of Ofloxacin Tablets with respect to the content of Ofloxacin.Other DTL MaduraiState lab Dec 2024

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.